Recent Findings in Colon Cancer Described by a Researcher from Odette Cancer Centre (Cost-effectiveness analysis of bevacizumab biosimilars for metastatic colorectal cancer: A comparative study using real-world data)

MLA

“Recent Findings in Colon Cancer Described by a Researcher from Odette Cancer Centre (Cost-Effectiveness Analysis of Bevacizumab Biosimilars for Metastatic Colorectal Cancer: A Comparative Study Using Real-World Data).” Obesity, Fitness & Wellness Week, Sept. 2024, p. 2298. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.809526064&authtype=sso&custid=ns315887.

APA

Recent Findings in Colon Cancer Described by a Researcher from Odette Cancer Centre (Cost-effectiveness analysis of bevacizumab biosimilars for metastatic colorectal cancer: A comparative study using real-world data). (2024, September 28). Obesity, Fitness & Wellness Week, 2298.

Chicago

Obesity, Fitness & Wellness Week. 2024. “Recent Findings in Colon Cancer Described by a Researcher from Odette Cancer Centre (Cost-Effectiveness Analysis of Bevacizumab Biosimilars for Metastatic Colorectal Cancer: A Comparative Study Using Real-World Data),” September 28. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.809526064&authtype=sso&custid=ns315887.